Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.7M Buy
+1,227,040
New +$9.53M 0.02% 501
2025
Q3
Sell
-512,200
Closed -$4.59M 1189
2025
Q2
$4.59M Buy
+512,200
New +$4.77M 0.01% 524
2024
Q1
Sell
-384,000
Closed -$2.3M 942
2023
Q4
$2.3M Hold
384,000
0.01% 607
2023
Q3
$2.72M Buy
+384,000
New +$2.76M 0.01% 490

Other funds holding BCRX

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's BCRX Position: Q1 2026 in Review

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund opened a new position in BioCryst Pharmaceuticals (BCRX) in Q1 2026: 1,227,040 shares worth $11.7M. The stake represents 0.02% of the portfolio and ranks #501 among its holdings. This is a return to the name: Healthcare of Ontario Pension Plan (HOOPP) Trust Fund previously reported a position in BCRX as recently as Q2 2025.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in BCRX in Q3 2023 and has held it in 4 quarters since. 301 funds tracked by Wall St. Rank hold BCRX as of Q1 2026.

  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund held 1,227,040 shares of BioCryst Pharmaceuticals worth $11.7M as of Q1 2026.
  • BioCryst Pharmaceuticals was a new Healthcare of Ontario Pension Plan (HOOPP) Trust Fund position in Q1 2026.
  • BioCryst Pharmaceuticals made up 0.02% of Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's portfolio in Q1 2026, its #501 holding.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in BioCryst Pharmaceuticals in Q3 2023 and has held it in 4 quarters since.
  • 301 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q1 2026.

Based on Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's 13F filing for Q1 2026, filed 14 May 2026.